Lisa Wahlström
Biographic Data
| ID | 7979678 |
|---|---|
| NAME | Lisa Wahlström |
| GIVEN NAMES | Lisa |
| FAMILY NAME | Wahlström |
| SIGNATURE | WAHLSTRÖM L |
| AFFILIATIONS | Sunderby sjukhus |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Serious adverse drug events associated with psychotropic treatment of bipolar or schizoaffective disorder
Serious ADEs related to treatment of bipolar (BD) or schizoaffective disorder (SZD) were uncommon but not rare. Older individuals were particularly at risk. The risk was higher in individuals exposed to lithium. Serum lithium concentration should always be checked when patients present with new or unclear somatic symptoms. However, severe ADEs also occurred with other mood stabilisers and other psychotropic drugs
No prominent works on this page.
Serious adverse drug events associated with psychotropic treatment of bipolar or schizoaffective disorder
Serious ADEs related to treatment of bipolar (BD) or schizoaffective disorder (SZD) were uncommon but not rare. Older individuals were particularly at risk. The risk was higher in individuals exposed to lithium. Serum lithium concentration should always be checked when patients present with new or unclear somatic symptoms. However, severe ADEs also occurred with other mood stabilisers and other psychotropic drugs
Adverse effect (1 work) · Bipolar disorder (1 work) · Bipolar Disorder and Treatment (1 work) · Cohort (1 work) · Cohort study (1 work) · Confidence interval (1 work) · Electroconvulsive Therapy Studies (1 work) · Incidence (geometry (1 work) · Internal Medicine (1 work) · Lithium (medication (1 work)